ACE2 - Angiotensin I Converting Enzyme 2 |Elisa - Clia - Antibody - Protein

Background

Angiotensin I Converting Enzyme 2 (ACE2) is an enzyme that plays a critical role in the renin-angiotensin system (RAS) by counterbalancing the actions of ACE. ACE2 converts angiotensin II, a potent vasoconstrictor, into angiotensin-(1-7), a peptide with vasodilatory and anti-inflammatory properties. ACE2 has garnered significant attention as the receptor for the spike protein of SARS-CoV-2, the virus responsible for COVID-19, highlighting its importance in both cardiovascular health and infectious disease.Angiotensin converting enzyme 2 (ACE2) is an enzyme found primarily on the surface of cells in the lungs, heart, kidneys, and intestines. Unlike ACE, which converts angiotensin I to angiotensin II, ACE2 counteracts the effects of ACE by converting angiotensin II to angiotensin-(1-7), which promotes vasodilation and has anti-inflammatory properties. ACE2 also serves as the entry receptor for coronaviruses such as SARS-CoV-2, the virus responsible for the COVID-19 pandemic, facilitating viral entry into host cells. The interaction between SARS-CoV-2 spike protein and ACE2 is crucial for viral infectivity and pathogenesis. Dysregulation of ACE2 expression and activity has been implicated in various diseases, including hypertension, cardiovascular disease, and acute respiratory distress syndrome (ARDS). Understanding the role of ACE2 in viral infections has prompted research into potential therapeutic strategies targeting this enzyme, including recombinant ACE2, ACE2 activators, and ACE2-based vaccines. Modulating ACE2 activity may hold promise not only for managing COVID-19 but also for treating other related respiratory illnesses and cardiovascular conditions

Protein Structure

ACE2 is a type I transmembrane protein with the following structural features:

• N-terminal peptidase domain (PD): This domain contains the active site responsible for the enzymatic activity of ACE2, converting angiotensin II to angiotensin-(1-7).
• Collectrin-like domain (CLD): Located towards the C-terminus, this domain is involved in dimerization and interaction with other proteins.
• Transmembrane region: Anchors the protein to the cell membrane.
• Cytoplasmic tail: A short intracellular segment involved in signal transduction and interactions with intracellular proteins.

Classification and Subtypes

ACE2 is classified as a carboxypeptidase and a member of the M2 metalloprotease family. Unlike ACE, which has two isoforms, ACE2 primarily exists as a single isoform but may have different functional states based on post-translational modifications and interactions with other proteins.

Function and Biological Significance

ACE2 has several critical roles in physiological processes:

1. Regulation of Blood Pressure: By converting angiotensin II into angiotensin-(1-7), ACE2 reduces blood pressure and mitigates the vasoconstrictive, pro-inflammatory, and pro-fibrotic effects of angiotensin II.
2. Cardiovascular Protection: Angiotensin-(1-7) exerts protective effects on the cardiovascular system, including vasodilation, anti-inflammatory actions, and inhibition of cell proliferation.
3. Renal Function: ACE2 helps maintain kidney function by balancing the effects of angiotensin II and angiotensin-(1-7) on renal blood flow and sodium reabsorption.
4. Lung Function: ACE2 is highly expressed in the lungs and plays a role in protecting against acute lung injury and inflammation.
5. SARS-CoV-2 Receptor: ACE2 serves as the entry point for the SARS-CoV-2 virus, making it a critical factor in COVID-19 infection and pathogenesis.

Interactions

ACE2 interacts with various molecules and proteins:

1. Angiotensin II: The primary substrate of ACE2, which is converted to angiotensin-(1-7).
2. Angiotensin-(1-7): The product of ACE2 enzymatic activity, which binds to the Mas receptor to exert its biological effects.
3. SARS-CoV-2 Spike Protein: The spike protein of the virus binds to ACE2 to facilitate viral entry into host cells.
4. Renin-Angiotensin System Components: ACE2 interacts indirectly with components of the RAS to balance the effects of angiotensin peptides.
5. Transmembrane Proteins: ACE2 interacts with other membrane proteins, which may influence its localization and function.

Clinical Significance

ACE2 has significant clinical implications in various diseases and conditions:

1. Hypertension: ACE2 activity can counteract the effects of high levels of angiotensin II, offering potential therapeutic strategies for managing hypertension.
2. Heart Failure: Enhanced ACE2 activity or administration of angiotensin-(1-7) may provide benefits in heart failure by reducing myocardial fibrosis and improving cardiac function.
3. Kidney Diseases: ACE2's role in modulating angiotensin II levels makes it a target for treating kidney diseases characterized by hyperactivity of the RAS.
4. Acute Respiratory Distress Syndrome (ARDS): ACE2 has protective effects in the lungs, and its modulation could be beneficial in ARDS and other inflammatory lung conditions.
5. COVID-19: ACE2's role as the entry receptor for SARS-CoV-2 has profound implications for understanding the pathogenesis of COVID-19 and developing therapeutic interventions.

Summary

Angiotensin I Converting Enzyme 2 (ACE2) is a critical enzyme in the renin-angiotensin system, functioning to counterbalance the effects of ACE by converting angiotensin II into angiotensin-(1-7). This conversion results in vasodilatory, anti-inflammatory, and anti-fibrotic effects, contributing to cardiovascular, renal, and pulmonary health. ACE2 is also the receptor for SARS-CoV-2, the virus responsible for COVID-19, highlighting its importance in infectious disease. Understanding the structure, function, interactions, and clinical significance of ACE2 provides valuable insights into its roles in health and disease, particularly in hypertension, heart failure, kidney diseases, lung conditions, and COVID-19.